VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight
DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, ...
TMCnet8h
Micro Bioreactor System Market Booms at 10.7% CAGR - Innovations in Pharma & Biotech Drive Growth | Valuates Reports
The Global Market for Micro Bioreactor System was estimated to be worth USD 134.7 Million in 2023 and is forecast to a readjusted size of USD 276.7 Million by 2030 with a CAGR of 10.7% during the ...
The evolution of pharma marketing: How to reach consumers in the age of digital health
Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...
Actinium Pharmaceuticals reports Actimab-A + CLAG-M trial results
Actinium Pharmaceuticals (ATNM) announced that results from the clinical trial evaluating Actimab-A in combination with the chemotherapy CLAG-M ...
China SXT Pharmaceuticals regains compliance with Nasdaq
China SXT Pharmaceuticals (SXTC) announced that the Company received a written notification from the Listing Qualifications Department of the ...
Stada plans to launch IPO as soon as Wednesday, sources say
FRANKFURT (Reuters) -German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two ...
European Supermarket Magazine15h
As Trade War Intensifies, Reckitt May Be More Exposed Than Some Rivals
Some investors fear Reckitt may be forced to raise its prices in the US, or face higher costs, due to its low manufacturing ...
Asana Q4 2024 Plunge Reaction, Despite Future Revenue Potential
Asana's 2024 results showed mixed performance, with 11% sales growth and positive free cash flow. See why I rate ASAN stock a ...